Bixiye
QP40-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2024
Natiijooyinka Raadinta
Soo bandhiga 2061 - 2070 ee natiijooyinka 4163
Bixiye
2024 May Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Bixiye
P34-24 Updated Reimbursement Policies, Effective July 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Bixiye
QP105-23 Change in Facility Unbundling Reviews for Members of Other Blue Plans
Taariikhda uu dhaqangalayo Barnaamijka: Des 27, 2023
Bixiye
QP106-23 Update for New to Market Medical Drugs: Casgevy and Lyfgenia
Taariikhda uu dhaqangalayo Barnaamijka: Des 27, 2023
Bixiye
QP107-23 Provider Press: Q4 2023
Taariikhda uu dhaqangalayo Barnaamijka: Des 27, 2023
Bixiye
QP108-23 Commercial Pharmacy Benefit Exclusion for Adzynma
Taariikhda uu dhaqangalayo Barnaamijka: Des 27, 2023
Bixiye
QP109-23 MHCP Pharmacy Benefit Exclusion for Adzynma and Loqtorzi™
Taariikhda uu dhaqangalayo Barnaamijka: Des 27, 2023
Bixiye
QP99-23 Update for New to Market Medical Drugs: Zymfentra
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2023